Oncology Review 2025 Presented by Scripps Cancer Center
Scripps Cancer Center’s 2025 Oncology Review is a dynamic one-day conference designed to provide physicians and advanced practice providers with a comprehensive overview of the latest advancements in the treatment of lung, pancreatic, colorectal, and breast cancers. Led by a multidisciplinary team of expert
medical oncologists, radiation oncologists, and surgeons, the program will highlight cutting-edge clinical data and practice-changing insights from recently published studies and major national conference presentations. Through a combination of interactive casebased discussions and engaging didactic lectures,
participants will gain valuable insights into managing complex clinical scenarios and translating evidencebased knowledge into real-world practice. Attendees will leave equipped with practical tools and strategies to enhance patient outcomes, improve quality of life, and raise the standard of care for individuals facing these challenging malignancies
Educational Objectives
After attending this live activity, participants should be able to:
- Integrate evidence-based treatment strategies into clinical practice to optimize patient outcomes and clinical care.
- Evaluate the latest advances in clinical oncology research and their implications for patient care.
- Examine the impact of novel diagnostic techniques in the management and assessment of various oncologic malignancies.
- Recognize and manage common and more recently appreciated side effects of cancer therapy including cardiotoxicities and immunerelated adverse events.
- Implement multidisciplinary collaboration and shared decision making into the management of complex patient cases and addressing treatment-related complications.
The Scripps MD Anderson Cancer Center Oncology Update 2025 is best for oncologists, hematologists, internists, advanced practice providers, and trainees who want CME‑accredited, expert‑led updates on the latest advances in cancer care, delivered in collaboration with MD Anderson Cancer Center.
